DK1791537T3 - 3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase - Google Patents

3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase

Info

Publication number
DK1791537T3
DK1791537T3 DK05785433.3T DK05785433T DK1791537T3 DK 1791537 T3 DK1791537 T3 DK 1791537T3 DK 05785433 T DK05785433 T DK 05785433T DK 1791537 T3 DK1791537 T3 DK 1791537T3
Authority
DK
Denmark
Prior art keywords
casein kinase
arylthioindole
analogues
inhibitors
carboxamide derivatives
Prior art date
Application number
DK05785433.3T
Other languages
English (en)
Inventor
William Arthur Metz Jr
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK1791537T3 publication Critical patent/DK1791537T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DK05785433.3T 2004-08-19 2005-08-19 3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase DK1791537T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60334804P 2004-08-19 2004-08-19
PCT/US2005/029306 WO2006023590A1 (en) 2004-08-19 2005-08-19 3-ARYLTHIOINDOLE-2-CARBOXAMIDE DERIVATIVES AND ANALOGS THEREOF AS INHIBITORS OF CASEIN KINASE Iϵ

Publications (1)

Publication Number Publication Date
DK1791537T3 true DK1791537T3 (da) 2010-03-01

Family

ID=35311784

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05785433.3T DK1791537T3 (da) 2004-08-19 2005-08-19 3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase

Country Status (19)

Country Link
US (1) US8008340B2 (da)
EP (1) EP1791537B1 (da)
JP (1) JP4931814B2 (da)
KR (1) KR20070045264A (da)
CN (1) CN101039666A (da)
AT (1) ATE445396T1 (da)
AU (1) AU2005277460A1 (da)
BR (1) BRPI0514397A (da)
CA (1) CA2577511A1 (da)
DE (1) DE602005017162D1 (da)
DK (1) DK1791537T3 (da)
ES (1) ES2334927T3 (da)
IL (1) IL181155A0 (da)
MX (1) MX2007001077A (da)
PL (1) PL1791537T3 (da)
PT (1) PT1791537E (da)
RU (1) RU2391098C2 (da)
SI (1) SI1791537T1 (da)
WO (1) WO2006023590A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201001330A1 (ru) * 2008-02-22 2011-04-29 Айрм Ллк Соединения и композиции в качестве модуляторов активности gpr119
US9018238B2 (en) 2009-02-12 2015-04-28 Pharmadesign, Inc. Inhibitor of casein kinase 1δ and casein kinase 1ε
ES2460065T3 (es) * 2009-10-28 2014-05-13 Pfizer Inc. Derivados de imidazol como inhibidores de la caseína quinasa
US20130059850A1 (en) * 2010-05-06 2013-03-07 Merck Sharp & Dohme Corp. Aza-indole derivatives useful as modulators of faah
US8710231B2 (en) * 2010-08-09 2014-04-29 Pharmadesign, Inc. Inhibitor of casein kinase 1delta and casein kinase 1E
KR101350077B1 (ko) * 2010-12-13 2014-01-14 한국화학연구원 신규한 3-인돌리논 유도체 및 이를 포함하는 조성물
DK2835131T3 (da) * 2010-12-14 2017-12-04 Electrophoretics Ltd Inhibitorer af kaseinkinase 1 delta (CK1delta)
MX361457B (es) 2012-05-11 2018-12-06 Reset Therapeutics Inc Sulfonamidas que contienen carbazol como moduladoras de criptocromo.
TWI690521B (zh) 2014-04-07 2020-04-11 美商同步製藥公司 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705934A1 (de) * 1987-02-25 1988-09-08 Nattermann A & Cie Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
AU6254294A (en) * 1993-02-24 1994-09-14 Merck & Co., Inc. Inhibitors of hiv reverse transcriptase
CA2375450C (en) * 1999-06-08 2009-04-28 Aventis Pharmaceuticals Inc. Screening methods for altering circadian rhythm proteins
BR0308391A (pt) * 2002-03-13 2005-01-11 Pharmacia & Upjohn Co Llc Derivados de pirazolo(1,5-a)piridina como moduladores neurotransmissores
WO2004014300A2 (en) * 2002-08-09 2004-02-19 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2005061498A1 (en) * 2003-12-11 2005-07-07 Aventis Pharmaceuticals Inc. Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon

Also Published As

Publication number Publication date
ATE445396T1 (de) 2009-10-15
US8008340B2 (en) 2011-08-30
DE602005017162D1 (de) 2009-11-26
AU2005277460A1 (en) 2006-03-02
WO2006023590A1 (en) 2006-03-02
IL181155A0 (en) 2007-07-04
RU2391098C2 (ru) 2010-06-10
BRPI0514397A (pt) 2008-06-10
EP1791537A1 (en) 2007-06-06
ES2334927T3 (es) 2010-03-17
PL1791537T3 (pl) 2010-04-30
JP4931814B2 (ja) 2012-05-16
KR20070045264A (ko) 2007-05-02
SI1791537T1 (sl) 2010-02-26
CN101039666A (zh) 2007-09-19
RU2007109813A (ru) 2008-09-27
US20070142454A1 (en) 2007-06-21
MX2007001077A (es) 2007-04-17
JP2008510704A (ja) 2008-04-10
EP1791537B1 (en) 2009-10-14
PT1791537E (pt) 2010-01-19
CA2577511A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
DK1791537T3 (da) 3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
TN2010000019A1 (en) Solid preparation comprising alogliptin and metformin hydrochloride
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
CO6361856A2 (es) Compuestos de pirazolopirimidina inhibidores de jak y metodos
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
EA201000805A1 (ru) Бис-(сульфониламино)производные в терапии 066
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
SE0400284D0 (sv) Novel compounds
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
TW200637810A (en) Substituted N-aminomethylenesulfonamides, their preparation and use as medicaments
NO20091889L (no) Inhibitorer av spiroketon acetyl-CoA karboksylase
EA201001013A1 (ru) Бис(сульфониламино)производные для применения в терапии
DK1753723T3 (da) Substituerede quinolinderivater som mitotiske kinesininhibitorer
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
NO20065719L (no) I det vesentlige rene 2-{[2-(2-metylamino-pyrimidin-4-yl)-1H-indol-5-karbonyl]-amlno}-3-(fenylpyridin-2-yl-amino)-propionsyre som en IkB kinaseinhibitor.
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
MX346186B (es) Inhibidores de proteina cinasas.
HK1133012A1 (en) Pyrimidinones as casein kinase ii (ck2) modulators
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
EA200970041A1 (ru) Ингибиторы акт (протеинкиназы в)
MX2022003504A (es) Inhibidor de irak y metodo de preparacion para el mismo y uso del mismo.